NICE adds further details on how the UK will pay more for drugsnews2025-12-05T16:29:30+00:00December 5th, 2025|Endpoints News|
German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozymenews2025-12-05T12:01:34+00:00December 5th, 2025|Endpoints News|
ACIP delays vote on hepatitis B birth dose to Fridaynews2025-12-04T20:51:19+00:00December 4th, 2025|Endpoints News|
Trump administration pushes end-of-term deadline for ‘most favored nation’ promisesnews2025-12-04T16:10:15+00:00December 4th, 2025|Endpoints News|
Nationwide Children’s SLC6A1 gene therapy shows early promisenews2025-12-04T13:00:54+00:00December 4th, 2025|Endpoints News|
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagennews2025-12-04T11:59:37+00:00December 4th, 2025|Endpoints News|
Hospitals challenge 340B rebate pilot program in Maine federal courtnews2025-12-02T20:24:15+00:00December 2nd, 2025|Endpoints News|
Pentagon seeks to add WuXi AppTec to military list: reportnews2025-12-02T20:19:07+00:00December 2nd, 2025|Endpoints News|
New York judge revives Bristol Myers dispute over Celgene dealnews2025-12-02T20:12:11+00:00December 2nd, 2025|Endpoints News|
As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myersnews2025-12-02T14:00:46+00:00December 2nd, 2025|Endpoints News|
